These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3144048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA, de Boer A, Colucci M, Jonker JJ, Collen D.
    Thromb Haemost; 1985 Oct 30; 54(3):725. PubMed ID: 3937271
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Selective thrombolysis of peripheral arterial occlusions using Rt-PA].
    Decrinis M, Pilger E, Stark G, Obernosterer A, Lafer M, Pieber D, Rumpl F, Lammer J.
    Vasa Suppl; 1990 Oct 30; 30():189-90. PubMed ID: 2127485
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
    Jia HY, Chen HZ, Pu SY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug 30; 16(4):214-6, 254. PubMed ID: 3147887
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA, Alfaro MJ, Rocha E.
    Thromb Haemost; 1985 Oct 30; 54(3):713-6. PubMed ID: 3937269
    [Abstract] [Full Text] [Related]

  • 10. Effect of caffein ingestion on plasma fibrinolytic potential.
    Wojta J, Kirchheimer JC, Peska MG, Binder BR.
    Thromb Haemost; 1988 Apr 08; 59(2):337-8. PubMed ID: 3133816
    [No Abstract] [Full Text] [Related]

  • 11. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.
    Korninger C, Wagner O, Binder BR.
    J Lab Clin Med; 1985 Jun 08; 105(6):718-24. PubMed ID: 3923146
    [Abstract] [Full Text] [Related]

  • 12. The role of the fibrinolytic system in thrombotic disease.
    Wiman B.
    Acta Med Scand Suppl; 1987 Jun 08; 715():169-71. PubMed ID: 3109214
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [50-year-old man with acute ischemia syndrome of both legs].
    von Scheidt W, Stäblein A, Autenrieth G.
    Internist (Berl); 1992 Apr 08; 33(4):265-8. PubMed ID: 1612851
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Eisenberg C.
    Pharmacotherapy; 1997 Apr 08; 17(4):850-2. PubMed ID: 9250573
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J, Rueda F.
    Sangre (Barc); 1985 Apr 08; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.